Maryland insurer sues Change Healthcare for $900K

Change Healthcare, a subsidiary of Optum and UnitedHealth Group, is being sued by an insurer, marking the latest in a litany of lawsuits filed against the company over its February 2023 data breach.

CareFirst BlueCross BlueShield of Maryland (CareFirst BCBS) has filed a complaint in state court, alleging that Change Healthcare was negligent in deploying inadequate security that inadvertently led to the successful cyberattack.  

UnitedHealth CEO Andrew Witty admitted during a Senate hearing that a single server, which lacked multifactor authentication, was the pathway through which hackers gained access and deployed ransomware on Change Healthcare’s network.

The attack exposed the personal data and medical records of nearly 200 million patients to the dark web, where the trove was put up for sale. The data breach is the largest ever reported by a healthcare entity. 

CareFirst BCBS stated that the incident resulted in the loss of a significant amount of data it needed to manage employer health plans, as well as components of its Medicare Advantage business. 

The insurer is seeking $900,000 in compensatory damages, along with attorney fees.

CareFirst BCBS serves approximately 3.5 million people in and around Maryland. Change Healthcare likely processes most of its medical claims, as the company handles the majority of claims for payers across the country.

The lawsuit was filed at the end of February, and a trial date has yet to be set.

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones are met. One of Verve's biggest gene therapies has already received the FDA's fast track designation.

American College of Cardiology Board of Governors Chair David E. Winchester, MD, MS, examines the many benefits of working with the American Medical Association House of Delegates to bring about significant change.

“Without a more concrete and stable policy on these tariffs from the current American administration, it is likely that most manufacturers will be forced to continuously change their internal forecasts and production plans," one analyst said.